Related Experiment Video
Updated: Apr 5, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Focusing on shared subpockets - new developments in fragment-based drug discovery
Eman M M Abdelraheem1,2, Carlos J Camacho3, Alexander Dömling1,2
1a 1 University of Groningen, A. Deusinglaan, Department of Drug Design, 1, Groningen 9700 AD, The Netherlands a.s.s.domling@rug.nl.
This study highlights a pocket-centric approach for protein-protein interaction (PPI) drug discovery. Combining computational screening and synthetic chemistry is crucial for developing novel PPI antagonists.
Area of Science:
- Computational chemistry
- Drug discovery
- Medicinal chemistry
Background:
- Protein-protein interactions (PPIs) are crucial for biological processes and represent key therapeutic targets.
- Existing software aids in identifying protein pockets for small-molecule drug design.
- Targeting PPIs offers a promising avenue for developing novel therapeutic agents.
Purpose of the Study:
- To present a pocket-centric methodology for analyzing PPI interfaces.
- To emphasize the role of multicomponent reaction chemistry in drug discovery for challenging targets.
- To offer expert perspectives on advancing PPI antagonist development.
Main Methods:
- Analysis of PPI interfaces using a pocket-centric strategy.
- Prioritization of pockets for small-molecule drug discovery.
- Application of multicomponent reaction chemistry for undruggable targets.
Main Results:
- The study outlines a method to prioritize pockets on protein surfaces for drug discovery.
- It underscores the significance of multicomponent reactions for targeting difficult protein-protein interactions.
- Perspectives on the current state and future of PPI drug discovery are provided.
Conclusions:
- Advancements in rational drug design for PPI antagonists require integrating efficient computational screening with rapid synthetic chemistry.
- Early drug discovery platforms can be enhanced by establishing feedback loops between clinical research and molecular design.
- A synergistic approach combining computational and synthetic methods is essential for future progress.
Related Concept Videos
Drug Discovery: Overview
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Protein-protein Interfaces

